Author Summary
Can TGF-β1 and SMAD-7 Predict Treatment Response in Low-Risk MDS?
New research examines how biomarkers at diagnosis might guide therapy decisions in myelodysplastic syndrome Understanding Myelodysplastic Syndrome Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoietic stem cells. It disrupts the normal formation of blood […]
